# Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

Study · id `cardio:ct-nct03183063` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03183063](<https://clinicaltrials.gov/study/NCT03183063>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03183063

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

## Technical summary

Registry record NCT03183063. Non-randomized; no masking; primary purpose diagnostic. Start 2017-04-12 (actual); primary completion 2019-04-23 (actual). Results posted on 2020-06-05.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 139 participants (enrolled count; ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Started: 2017-04-12 (actual) (ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Primary completion: 2019-04-23 (actual) (ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Completion: 2019-04-24 (actual) (ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Results first posted: 2020-06-05 (ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT03183063, source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03183063-2020-06-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events
- Condition: Pulmonary Thromboembolisms
- Condition: Pulmonary Embolism
- Intervention (Device): 4DCT and SPECT/CT
- Intervention (Device): 4DCT with BiPAP and SPECT/CT
- Intervention (Device): 4DCT with CTA in suspected PE
- Lead sponsor: Thomas Guerrero
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: cd1c09677b6de49d1705047028e8dc91318a6e2d99d41e3a23a744595f00aa75
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
